A detailed history of Tabor Asset Management, LP transactions in Chimerix Inc stock. As of the latest transaction made, Tabor Asset Management, LP holds 40,000 shares of CMRX stock, worth $341,599. This represents 0.18% of its overall portfolio holdings.

Number of Shares
40,000
Holding current value
$341,599
% of portfolio
0.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025

BUY
$3.25 - $8.51 $130,000 - $340,400
40,000 New
40,000 $340,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $748M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Tabor Asset Management, LP Portfolio

Follow Tabor Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tabor Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Tabor Asset Management, LP with notifications on news.